Market Flash: iSHARES MSCI Indonesia Investable Market Index Fund (EIDO:US) PRICE: 28.530 USD Down -0.360 (-1.246%) >>> BI: Rupiah Melemah Akibat Kondisi Eropa >>> Pertemuan FED pertimbangkan langkah baru dorong ekonomi >>> KIJA akan Terbitkan MEN Valas USD150 Juta >>> PT Indika Energy Perusahaan Teladan Dunia 2011 >>> Govt Promises Revision of Cost Recovery Regulation >>> BPMigas Demands PGN to Pay US$6 per MMBTU >>> Jababeka to Raise US$150 Million from Debt Markets >>> SCG Chemicals buys Chandra Asri >>> Solusi Tunas eyes Rp380 bio IPO >>> SMR Utama scouts Rp300 bio IPO >>> Alam Sutera picks two bond arrangers >>> ASII Tetap Rajai Penjualan Mobil Agustus 2011 >>> Perusahaan Thailand kuasai Saham TPIA senilai Rp 3,76 Triliun >>> Agis Main ke Tambang, Sahamnya Masuk Dalam Pengawasan >>> ACES Mendekati The Northern Agar Mau Kurangi Kepemilikan >>> IHSG masih harus berjuang terus bertahan diatas MA200 >>> Melirik Peluang Akumulasi di Saham Perbankan >>> Analisa Saham BUMI: Kuat Bertahan & Berpeluang Kembali Uptrend >>> Analisa Saham JSMR: Bertahan Di Support, What Next? >>> INDF Tertahan Di Area Support Kuat, Berpeluang Rebound >>> ASII Break Minor Support, Sell on Strength >>> ADRO Membentuk Descending Wedges, Berpeluang Rebound Terbatas >>> Wall Street ends flat as early gains evaporate >>> Fed begins policy meeting, tiptoes toward easing >>> Fed meeting to help decide on long-term Treasuries >>> Greece Makes 'Good Progress' in Reform Talks: EC >>> China worried Europe debt crisis will hit trade >>> China could roll out 4.65tr yuan stimulus package >>> IMF sees Mideast stagnation >>> NYMEX-Crude ends higher at Oct contract expiry >>> Asian Crude Palm Oil Up On Technical Buying, Soyoil >>> Foreign net Sell - 61.785.746

Senin, 07 Februari 2011

KLBF:In-line, but tougher outlook - Mandiri Sekuritas

The company’s unaudited net profit 2010 figure was in line with our expectation. This year, the company expects its sales to grow by 12-15% yoy and operating margin to be maintained at 17.5-18.5%. We prefer to take more conservative stance by having lower sales growth and operating margin projections. This supported our neutral call on the counter.

Better sales growth expected this year... KLBF posted sales of Rp10.2 tn in FY10F, an increase of 12.1% yoy. Sales from nutritional division posted the highest growth of 18.1% yoy to Rp2.3tn, representing 22.4% of total sales in 2010, followed by sales from prescribed pharmaceutical division (+16.1% yoy). On the contrary, sales from consumer health division declined by 1.8% yoy as a result of poor performance of energy drink. The company is still striving to revive the performance of its energy drink product, which still contributed around 22-25% of total sales for the consumer health. This year, the company targets sales to grow by 12-15% yoy, higher than our estimate of 11.7% yoy as we still have some concerns on rising inflationary pressures which might affect the company’s sales performance.

High net profit growth supported by lower tax rate. Since last year, KLBF’s corporate income tax was reduced to 20% as the company managed to increase its public share ownership to 40%. Coupled with lower tax rate applied to subsidiaries (from 28% in 2009 to 25% in 2010), the effective tax rate for the year is around 23-24%, much lower than that in 2009 of 28%-29%. Furthermore, the company also recorded lower minority interest in net earnings of subsidiaries to Rp62bn from Rp121bn in 2009 as the company increased its ownership in Enseval Putra Mega Trading (EPMT).

Skim milk prices have increased by 10% yoy. During the analyst meeting, the management highlighted the increase in skim milk prices by 10% yoy this year, yet believed that the impact of such increase will be manageable on the company’s performance. The management doesn’t expect a substantial high commodity prices which will pressure gross margin like what had happened in 2008 (gross margin dropped to 48.1% in 2008), hence an operating margin of 17.5-18.5% is expected this year.

Rp3,100/share TP is maintained. We maintained our TP at Rp3,100/share as we are still concerned with rising inflationary pressures that might affect the company’s performance this year. At the current price, the stock offers 6.9% upside potential. Maintain neutral.

Tidak ada komentar:

Posting Komentar